APO Research
Talk to an analyst

APO RESEARCH · REPORT

Metabotropic Glutamate Receptor 5

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Metabotropic Glutamate Receptor 5 Market Analysis and Forecast 2026-2032

22 December 2025190 pages

Choose your research edition.

Industry ResearchMetabotropic Glutamate Receptor 5 Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Metabotropic Glutamate Receptor 5 Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Metabotropic Glutamate Receptor 5 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Metabotropic Glutamate Receptor 5 Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Metabotropic Glutamate Receptor 5 Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Metabotropic Glutamate Receptor 5 market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Metabotropic Glutamate Receptor 5 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Metabotropic Glutamate Receptor 5 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Metabotropic Glutamate Receptor 5 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Metabotropic Glutamate Receptor 5 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Metabotropic Glutamate Receptor 5 include Addex Therapeutics Ltd, Aevi Genomic Medicine Inc, Bristol-Myers Squibb Company, Heptares Therapeutics Ltd, Merz Pharma GmbH & Co KgaA, Richter Gedeon Nyrt, Sumitomo Dainippon Pharma Co Ltd, Toray Industries Inc and Eli Lilly and Company, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Metabotropic Glutamate Receptor 5, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Metabotropic Glutamate Receptor 5, also provides the sales of main regions and countries. Of the upcoming market potential for Metabotropic Glutamate Receptor 5, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Metabotropic Glutamate Receptor 5 sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Metabotropic Glutamate Receptor 5 market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Metabotropic Glutamate Receptor 5 sales, projected growth trends, production technology, application and end-user industry.

Metabotropic Glutamate Receptor 5 Segment by Company

Addex Therapeutics Ltd

Aevi Genomic Medicine Inc

Bristol-Myers Squibb Company

Heptares Therapeutics Ltd

Merz Pharma GmbH & Co KgaA

Richter Gedeon Nyrt

Sumitomo Dainippon Pharma Co Ltd

Toray Industries Inc

Eli Lilly and Company

Novartis AG

Johnson & Johnson

Eisai Co Ltd

Metabotropic Glutamate Receptor 5 Segment by Type

Alloswitch-1

BMS-952048

BMS-955829

Dipraglurant ER

Others

Metabotropic Glutamate Receptor 5 Segment by Application

Major Depressive Disorder

Alcohol Addiction

Alzheimer's Disease

Others

Metabotropic Glutamate Receptor 5 Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Metabotropic Glutamate Receptor 5 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Metabotropic Glutamate Receptor 5 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Metabotropic Glutamate Receptor 5.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Metabotropic Glutamate Receptor 5 in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Metabotropic Glutamate Receptor 5 manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Metabotropic Glutamate Receptor 5 sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Metabotropic Glutamate Receptor 5 Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Alloswitch-1 Major Manufacturers Table 3. BMS-952048 Major Manufacturers Table 4. BMS-955829 Major Manufacturers Table 5. Dipraglurant ER Major Manufacturers Table 6. Others Major Manufacturers Table 7. Global Metabotropic Glutamate Receptor 5 Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Major Depressive Disorder Major Manufacturers Table 9. Alcohol Addiction Major Manufacturers Table 10. Alzheimer's Disease Major Manufacturers Table 11. Others Major Manufacturers Table 12. Metabotropic Glutamate Receptor 5 Industry Trends Table 13. Metabotropic Glutamate Receptor 5 Industry Drivers Table 14. Metabotropic Glutamate Receptor 5 Industry Opportunities and Challenges Table 15. Metabotropic Glutamate Receptor 5 Industry Restraints Table 16. Global Metabotropic Glutamate Receptor 5 Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Metabotropic Glutamate Receptor 5 Revenue by Region (2021-2026) & (US$ Million) Table 18. Global Metabotropic Glutamate Receptor 5 Revenue by Region (2027-2032) & (US$ Million) Table 19. Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Region (2021-2026) Table 20. Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Region (2027-2032) Table 21. Global Metabotropic Glutamate Receptor 5 Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 22. Global Metabotropic Glutamate Receptor 5 Sales by Region (2021-2026) & (k units) Table 23. Global Metabotropic Glutamate Receptor 5 Sales by Region (2027-2032) & (k units) Table 24. Global Metabotropic Glutamate Receptor 5 Sales Market Share by Region (2021-2026) Table 25. Global Metabotropic Glutamate Receptor 5 Sales Market Share by Region (2027-2032) Table 26. Global Metabotropic Glutamate Receptor 5 Revenue by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Manufacturers (2021-2026) Table 28. Global Metabotropic Glutamate Receptor 5 Sales by Manufacturers (US$ Million) & (2021-2026) Table 29. Global Metabotropic Glutamate Receptor 5 Sales Market Share by Manufacturers (2021-2026) Table 30. Global Metabotropic Glutamate Receptor 5 Sales Price (US$/unit) of Manufacturers (2021-2026) Table 31. Global Metabotropic Glutamate Receptor 5 Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 32. Global Metabotropic Glutamate Receptor 5 Key Manufacturers Manufacturing Sites & Headquarters Table 33. Global Metabotropic Glutamate Receptor 5 Manufacturers, Product Type & Application Table 34. Global Metabotropic Glutamate Receptor 5 Manufacturers' Establishment Date Table 35. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 36. Global Metabotropic Glutamate Receptor 5 by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 37. Global Metabotropic Glutamate Receptor 5 Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Metabotropic Glutamate Receptor 5 Revenue by Type (2021-2026) & (US$ Million) Table 39. Global Metabotropic Glutamate Receptor 5 Revenue by Type (2027-2032) & (US$ Million) Table 40. Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Type (2021-2026) Table 41. Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Type (2027-2032) Table 42. Global Metabotropic Glutamate Receptor 5 Sales by Type 2021 VS 2025 VS 2032 (k units) Table 43. Global Metabotropic Glutamate Receptor 5 Sales by Type (2021-2026) & (k units) Table 44. Global Metabotropic Glutamate Receptor 5 Sales by Type (2027-2032) & (k units) Table 45. Global Metabotropic Glutamate Receptor 5 Sales Market Share by Type (2021-2026) Table 46. Global Metabotropic Glutamate Receptor 5 Sales Market Share by Type (2027-2032) Table 47. Global Metabotropic Glutamate Receptor 5 Price by Type (2021-2026) & (US$/unit) Table 48. Global Metabotropic Glutamate Receptor 5 Price by Type (2027-2032) & (US$/unit) Table 49. Global Metabotropic Glutamate Receptor 5 Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Metabotropic Glutamate Receptor 5 Revenue by Application (2021-2026) & (US$ Million) Table 51. Global Metabotropic Glutamate Receptor 5 Revenue by Application (2027-2032) & (US$ Million) Table 52. Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Application (2021-2026) Table 53. Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Application (2027-2032) Table 54. Global Metabotropic Glutamate Receptor 5 Sales by Application 2021 VS 2025 VS 2032 (k units) Table 55. Global Metabotropic Glutamate Receptor 5 Sales by Application (2021-2026) & (k units) Table 56. Global Metabotropic Glutamate Receptor 5 Sales by Application (2027-2032) & (k units) Table 57. Global Metabotropic Glutamate Receptor 5 Sales Market Share by Application (2021-2026) Table 58. Global Metabotropic Glutamate Receptor 5 Sales Market Share by Application (2027-2032) Table 59. Global Metabotropic Glutamate Receptor 5 Price by Application (2021-2026) & (US$/unit) Table 60. Global Metabotropic Glutamate Receptor 5 Price by Application (2027-2032) & (US$/unit) Table 61. Addex Therapeutics Ltd Company Information Table 62. Addex Therapeutics Ltd Business Overview Table 63. Addex Therapeutics Ltd Metabotropic Glutamate Receptor 5 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 64. Addex Therapeutics Ltd Metabotropic Glutamate Receptor 5 Product Portfolio Table 65. Addex Therapeutics Ltd Recent Development Table 66. Aevi Genomic Medicine Inc Company Information Table 67. Aevi Genomic Medicine Inc Business Overview Table 68. Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 5 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 69. Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 5 Product Portfolio Table 70. Aevi Genomic Medicine Inc Recent Development Table 71. Bristol-Myers Squibb Company Company Information Table 72. Bristol-Myers Squibb Company Business Overview Table 73. Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 5 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 5 Product Portfolio Table 75. Bristol-Myers Squibb Company Recent Development Table 76. Heptares Therapeutics Ltd Company Information Table 77. Heptares Therapeutics Ltd Business Overview Table 78. Heptares Therapeutics Ltd Metabotropic Glutamate Receptor 5 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Heptares Therapeutics Ltd Metabotropic Glutamate Receptor 5 Product Portfolio Table 80. Heptares Therapeutics Ltd Recent Development Table 81. Merz Pharma GmbH & Co KgaA Company Information Table 82. Merz Pharma GmbH & Co KgaA Business Overview Table 83. Merz Pharma GmbH & Co KgaA Metabotropic Glutamate Receptor 5 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Merz Pharma GmbH & Co KgaA Metabotropic Glutamate Receptor 5 Product Portfolio Table 85. Merz Pharma GmbH & Co KgaA Recent Development Table 86. Richter Gedeon Nyrt Company Information Table 87. Richter Gedeon Nyrt Business Overview Table 88. Richter Gedeon Nyrt Metabotropic Glutamate Receptor 5 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Richter Gedeon Nyrt Metabotropic Glutamate Receptor 5 Product Portfolio Table 90. Richter Gedeon Nyrt Recent Development Table 91. Sumitomo Dainippon Pharma Co Ltd Company Information Table 92. Sumitomo Dainippon Pharma Co Ltd Business Overview Table 93. Sumitomo Dainippon Pharma Co Ltd Metabotropic Glutamate Receptor 5 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Sumitomo Dainippon Pharma Co Ltd Metabotropic Glutamate Receptor 5 Product Portfolio Table 95. Sumitomo Dainippon Pharma Co Ltd Recent Development Table 96. Toray Industries Inc Company Information Table 97. Toray Industries Inc Business Overview Table 98. Toray Industries Inc Metabotropic Glutamate Receptor 5 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Toray Industries Inc Metabotropic Glutamate Receptor 5 Product Portfolio Table 100. Toray Industries Inc Recent Development Table 101. Eli Lilly and Company Company Information Table 102. Eli Lilly and Company Business Overview Table 103. Eli Lilly and Company Metabotropic Glutamate Receptor 5 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Eli Lilly and Company Metabotropic Glutamate Receptor 5 Product Portfolio Table 105. Eli Lilly and Company Recent Development Table 106. Novartis AG Company Information Table 107. Novartis AG Business Overview Table 108. Novartis AG Metabotropic Glutamate Receptor 5 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Novartis AG Metabotropic Glutamate Receptor 5 Product Portfolio Table 110. Novartis AG Recent Development Table 111. Johnson & Johnson Company Information Table 112. Johnson & Johnson Business Overview Table 113. Johnson & Johnson Metabotropic Glutamate Receptor 5 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. Johnson & Johnson Metabotropic Glutamate Receptor 5 Product Portfolio Table 115. Johnson & Johnson Recent Development Table 116. Eisai Co Ltd Company Information Table 117. Eisai Co Ltd Business Overview Table 118. Eisai Co Ltd Metabotropic Glutamate Receptor 5 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 119. Eisai Co Ltd Metabotropic Glutamate Receptor 5 Product Portfolio Table 120. Eisai Co Ltd Recent Development Table 121. North America Metabotropic Glutamate Receptor 5 Revenue by Type (2021-2026) & (US$ Million) Table 122. North America Metabotropic Glutamate Receptor 5 Revenue by Type (2027-2032) & (US$ Million) Table 123. North America Metabotropic Glutamate Receptor 5 Sales by Type (2021-2026) & (k units) Table 124. North America Metabotropic Glutamate Receptor 5 Sales by Type (2027-2032) & (k units) Table 125. North America Metabotropic Glutamate Receptor 5 Sales Price by Type (2021-2026) & (US$/unit) Table 126. North America Metabotropic Glutamate Receptor 5 Sales Price by Type (2027-2032) & (US$/unit) Table 127. North America Metabotropic Glutamate Receptor 5 Revenue by Application (2021-2026) & (US$ Million) Table 128. North America Metabotropic Glutamate Receptor 5 Revenue by Application (2027-2032) & (US$ Million) Table 129. North America Metabotropic Glutamate Receptor 5 Sales by Application (2021-2026) & (k units) Table 130. North America Metabotropic Glutamate Receptor 5 Sales by Application (2027-2032) & (k units) Table 131. North America Metabotropic Glutamate Receptor 5 Sales Price by Application (2021-2026) & (US$/unit) Table 132. North America Metabotropic Glutamate Receptor 5 Sales Price by Application (2027-2032) & (US$/unit) Table 133. North America Metabotropic Glutamate Receptor 5 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 134. North America Metabotropic Glutamate Receptor 5 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 135. North America Metabotropic Glutamate Receptor 5 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 136. North America Metabotropic Glutamate Receptor 5 Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 137. North America Metabotropic Glutamate Receptor 5 Sales by Country (2021-2026) & (k units) Table 138. North America Metabotropic Glutamate Receptor 5 Sales by Country (2027-2032) & (k units) Table 139. North America Metabotropic Glutamate Receptor 5 Sales Price by Country (2021-2026) & (US$/unit) Table 140. North America Metabotropic Glutamate Receptor 5 Sales Price by Country (2027-2032) & (US$/unit) Table 141. United States Metabotropic Glutamate Receptor 5 Revenue (2021-2032) & (US$ Million) Table 142. Canada Metabotropic Glutamate Receptor 5 Revenue (2021-2032) & (US$ Million) Table 143. Mexico Metabotropic Glutamate Receptor 5 Revenue (2021-2032) & (US$ Million) Table 144. Europe Metabotropic Glutamate Receptor 5 Revenue by Type (2021-2026) & (US$ Million) Table 145. Europe Metabotropic Glutamate Receptor 5 Revenue by Type (2027-2032) & (US$ Million) Table 146. Europe Metabotropic Glutamate Receptor 5 Sales by Type (2021-2026) & (k units) Table 147. Europe Metabotropic Glutamate Receptor 5 Sales by Type (2027-2032) & (k units) Table 148. Europe Metabotropic Glutamate Receptor 5 Sales Price by Type (2021-2026) & (US$/unit) Table 149. Europe Metabotropic Glutamate Receptor 5 Sales Price by Type (2027-2032) & (US$/unit) Table 150. Europe Metabotropic Glutamate Receptor 5 Revenue by Application (2021-2026) & (US$ Million) Table 151. Europe Metabotropic Glutamate Receptor 5 Revenue by Application (2027-2032) & (US$ Million) Table 152. Europe Metabotropic Glutamate Receptor 5 Sales by Application (2021-2026) & (k units) Table 153. Europe Metabotropic Glutamate Receptor 5 Sales by Application (2027-2032) & (k units) Table 154. Europe Metabotropic Glutamate Receptor 5 Sales Price by Application (2021-2026) & (US$/unit) Table 155. Europe Metabotropic Glutamate Receptor 5 Sales Price by Application (2027-2032) & (US$/unit) Table 156. Europe Metabotropic Glutamate Receptor 5 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 157. Europe Metabotropic Glutamate Receptor 5 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 158. Europe Metabotropic Glutamate Receptor 5 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 159. Europe Metabotropic Glutamate Receptor 5 Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 160. Europe Metabotropic Glutamate Receptor 5 Sales by Country (2021-2026) & (k units) Table 161. Europe Metabotropic Glutamate Receptor 5 Sales by Country (2027-2032) & (k units) Table 162. Europe Metabotropic Glutamate Receptor 5 Sales Price by Country (2021-2026) & (US$/unit) Table 163. Europe Metabotropic Glutamate Receptor 5 Sales Price by Country (2027-2032) & (US$/unit) Table 164. Germany Metabotropic Glutamate Receptor 5 Revenue (2021-2032) & (US$ Million) Table 165. France Metabotropic Glutamate Receptor 5 Revenue (2021-2032) & (US$ Million) Table 166. U.K. Metabotropic Glutamate Receptor 5 Revenue (2021-2032) & (US$ Million) Table 167. Italy Metabotropic Glutamate Receptor 5 Revenue (2021-2032) & (US$ Million) Table 168. Russia Metabotropic Glutamate Receptor 5 Revenue (2021-2032) & (US$ Million) Table 169. Spain Metabotropic Glutamate Receptor 5 Revenue (2021-2032) & (US$ Million) Table 170. Netherlands Metabotropic Glutamate Receptor 5 Revenue (2021-2032) & (US$ Million) Table 171. Switzerland Metabotropic Glutamate Receptor 5 Revenue (2021-2032) & (US$ Million) Table 172. Sweden Metabotropic Glutamate Receptor 5 Revenue (2021-2032) & (US$ Million) Table 173. Poland Metabotropic Glutamate Receptor 5 Revenue (2021-2032) & (US$ Million) Table 174. China Metabotropic Glutamate Receptor 5 Revenue by Type (2021-2026) & (US$ Million) Table 175. China Metabotropic Glutamate Receptor 5 Revenue by Type (2027-2032) & (US$ Million) Table 176. China Metabotropic Glutamate Receptor 5 Sales by Type (2021-2026) & (k units) Table 177. China Metabotropic Glutamate Receptor 5 Sales by Type (2027-2032) & (k units) Table 178. China Metabotropic Glutamate Receptor 5 Sales Price by Type (2021-2026) & (US$/unit) Table 179. China Metabotropic Glutamate Receptor 5 Sales Price by Type (2027-2032) & (US$/unit) Table 180. China Metabotropic Glutamate Receptor 5 Revenue by Application (2021-2026) & (US$ Million) Table 181. China Metabotropic Glutamate Receptor 5 Revenue by Application (2027-2032) & (US$ Million) Table 182. China Metabotropic Glutamate Receptor 5 Sales by Application (2021-2026) & (k units) Table 183. China Metabotropic Glutamate Receptor 5 Sales by Application (2027-2032) & (k units) Table 184. China Metabotropic Glutamate Receptor 5 Sales Price by Application (2021-2026) & (US$/unit) Table 185. China Metabotropic Glutamate Receptor 5 Sales Price by Application (2027-2032) & (US$/unit) Table 186. Asia Metabotropic Glutamate Receptor 5 Revenue by Type (2021-2026) & (US$ Million) Table 187. Asia Metabotropic Glutamate Receptor 5 Revenue by Type (2027-2032) & (US$ Million) Table 188. Asia Metabotropic Glutamate Receptor 5 Sales by Type (2021-2026) & (k units) Table 189. Asia Metabotropic Glutamate Receptor 5 Sales by Type (2027-2032) & (k units) Table 190. Asia Metabotropic Glutamate Receptor 5 Sales Price by Type (2021-2026) & (US$/unit) Table 191. Asia Metabotropic Glutamate Receptor 5 Sales Price by Type (2027-2032) & (US$/unit) Table 192. Asia Metabotropic Glutamate Receptor 5 Revenue by Application (2021-2026) & (US$ Million) Table 193. Asia Metabotropic Glutamate Receptor 5 Revenue by Application (2027-2032) & (US$ Million) Table 194. Asia Metabotropic Glutamate Receptor 5 Sales by Application (2021-2026) & (k units) Table 195. Asia Metabotropic Glutamate Receptor 5 Sales by Application (2027-2032) & (k units) Table 196. Asia Metabotropic Glutamate Receptor 5 Sales Price by Application (2021-2026) & (US$/unit) Table 197. Asia Metabotropic Glutamate Receptor 5 Sales Price by Application (2027-2032) & (US$/unit) Table 198. Asia Metabotropic Glutamate Receptor 5 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 199. Asia Metabotropic Glutamate Receptor 5 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 200. Asia Metabotropic Glutamate Receptor 5 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 201. Asia Metabotropic Glutamate Receptor 5 Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 202. Asia Metabotropic Glutamate Receptor 5 Sales by Country (2021-2026) & (k units) Table 203. Asia Metabotropic Glutamate Receptor 5 Sales by Country (2027-2032) & (k units) Table 204. Asia Metabotropic Glutamate Receptor 5 Sales Price by Country (2021-2026) & (US$/unit) Table 205. Asia Metabotropic Glutamate Receptor 5 Sales Price by Country (2027-2032) & (US$/unit) Table 206. Japan Metabotropic Glutamate Receptor 5 Revenue (2021-2032) & (US$ Million) Table 207. South Korea Metabotropic Glutamate Receptor 5 Revenue (2021-2032) & (US$ Million) Table 208. India Metabotropic Glutamate Receptor 5 Revenue (2021-2032) & (US$ Million) Table 209. Australia Metabotropic Glutamate Receptor 5 Revenue (2021-2032) & (US$ Million) Table 210. Taiwan Metabotropic Glutamate Receptor 5 Revenue (2021-2032) & (US$ Million) Table 211. Southeast Asia Metabotropic Glutamate Receptor 5 Revenue (2021-2032) & (US$ Million) Table 212. SAMEA Metabotropic Glutamate Receptor 5 Revenue by Type (2021-2026) & (US$ Million) Table 213. SAMEA Metabotropic Glutamate Receptor 5 Revenue by Type (2027-2032) & (US$ Million) Table 214. SAMEA Metabotropic Glutamate Receptor 5 Sales by Type (2021-2026) & (k units) Table 215. SAMEA Metabotropic Glutamate Receptor 5 Sales by Type (2027-2032) & (k units) Table 216. SAMEA Metabotropic Glutamate Receptor 5 Sales Price by Type (2021-2026) & (US$/unit) Table 217. SAMEA Metabotropic Glutamate Receptor 5 Sales Price by Type (2027-2032) & (US$/unit) Table 218. SAMEA Metabotropic Glutamate Receptor 5 Revenue by Application (2021-2026) & (US$ Million) Table 219. SAMEA Metabotropic Glutamate Receptor 5 Revenue by Application (2027-2032) & (US$ Million) Table 220. SAMEA Metabotropic Glutamate Receptor 5 Sales by Application (2021-2026) & (k units) Table 221. SAMEA Metabotropic Glutamate Receptor 5 Sales by Application (2027-2032) & (k units) Table 222. SAMEA Metabotropic Glutamate Receptor 5 Sales Price by Application (2021-2026) & (US$/unit) Table 223. SAMEA Metabotropic Glutamate Receptor 5 Sales Price by Application (2027-2032) & (US$/unit) Table 224. SAMEA Metabotropic Glutamate Receptor 5 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 225. SAMEA Metabotropic Glutamate Receptor 5 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 226. SAMEA Metabotropic Glutamate Receptor 5 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 227. SAMEA Metabotropic Glutamate Receptor 5 Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 228. SAMEA Metabotropic Glutamate Receptor 5 Sales by Country (2021-2026) & (k units) Table 229. SAMEA Metabotropic Glutamate Receptor 5 Sales by Country (2027-2032) & (k units) Table 230. SAMEA Metabotropic Glutamate Receptor 5 Sales Price by Country (2021-2026) & (US$/unit) Table 231. SAMEA Metabotropic Glutamate Receptor 5 Sales Price by Country (2027-2032) & (US$/unit) Table 232. Brazil Metabotropic Glutamate Receptor 5 Revenue (2021-2032) & (US$ Million) Table 233. Argentina Metabotropic Glutamate Receptor 5 Revenue (2021-2032) & (US$ Million) Table 234. Chile Metabotropic Glutamate Receptor 5 Revenue (2021-2032) & (US$ Million) Table 235. Colombia Metabotropic Glutamate Receptor 5 Revenue (2021-2032) & (US$ Million) Table 236. Peru Metabotropic Glutamate Receptor 5 Revenue (2021-2032) & (US$ Million) Table 237. Saudi Arabia Metabotropic Glutamate Receptor 5 Revenue (2021-2032) & (US$ Million) Table 238. Israel Metabotropic Glutamate Receptor 5 Revenue (2021-2032) & (US$ Million) Table 239. UAE Metabotropic Glutamate Receptor 5 Revenue (2021-2032) & (US$ Million) Table 240. Turkey Metabotropic Glutamate Receptor 5 Revenue (2021-2032) & (US$ Million) Table 241. Iran Metabotropic Glutamate Receptor 5 Revenue (2021-2032) & (US$ Million) Table 242. Egypt Metabotropic Glutamate Receptor 5 Revenue (2021-2032) & (US$ Million) Table 243. Key Raw Materials Table 244. Raw Materials Key Suppliers Table 245. Metabotropic Glutamate Receptor 5 Distributors List Table 246. Metabotropic Glutamate Receptor 5 Customers List Table 247. Research Programs/Design for This Report Table 248. Authors List of This Report Table 249. Secondary Sources Table 250. Primary Sources List of Figures Figure 1. Metabotropic Glutamate Receptor 5 Image Figure 2. Global Metabotropic Glutamate Receptor 5 Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Metabotropic Glutamate Receptor 5 Market Size Share 2021 VS 2025 VS 2032 Figure 4. Alloswitch-1 Image Figure 5. BMS-952048 Image Figure 6. BMS-955829 Image Figure 7. Dipraglurant ER Image Figure 8. Others Image Figure 9. Global Metabotropic Glutamate Receptor 5 Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Metabotropic Glutamate Receptor 5 Market Size Share 2021 VS 2025 VS 2032 Figure 11. Major Depressive Disorder Image Figure 12. Alcohol Addiction Image Figure 13. Alzheimer's Disease Image Figure 14. Others Image Figure 15. Global Metabotropic Glutamate Receptor 5 Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Metabotropic Glutamate Receptor 5 Revenue (2021-2032) & (US$ Million) Figure 17. Global Metabotropic Glutamate Receptor 5 Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Region: 2025 Versus 2032 Figure 19. Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Region (2021-2032) Figure 20. Global Metabotropic Glutamate Receptor 5 Sales (2021-2032) & (k units) Figure 21. Global Metabotropic Glutamate Receptor 5 Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 22. Global Metabotropic Glutamate Receptor 5 Sales Market Share by Region (2021-2032) Figure 23. US & Canada & Mexico Metabotropic Glutamate Receptor 5 Sales YoY (2021-2032) & (k units) Figure 24. Europe Metabotropic Glutamate Receptor 5 Sales YoY (2021-2032) & (k units) Figure 25. China Metabotropic Glutamate Receptor 5 Sales YoY (2021-2032) & (k units) Figure 26. Asia (Excluding China) Metabotropic Glutamate Receptor 5 Sales YoY (2021-2032) & (k units) Figure 27. South America, Middle East and Africa Metabotropic Glutamate Receptor 5 Sales YoY (2021-2032) & (k units) Figure 28. Global Metabotropic Glutamate Receptor 5 Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 29. Global Metabotropic Glutamate Receptor 5 Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 30. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Global Metabotropic Glutamate Receptor 5 Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 32. Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Type (2021-2032) Figure 34. Global Metabotropic Glutamate Receptor 5 Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 35. Global Metabotropic Glutamate Receptor 5 Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 36. Global Metabotropic Glutamate Receptor 5 Sales Market Share by Type (2021-2032) Figure 37. Global Metabotropic Glutamate Receptor 5 Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 38. Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Application (2021-2032) Figure 40. Global Metabotropic Glutamate Receptor 5 Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 41. Global Metabotropic Glutamate Receptor 5 Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 42. Global Metabotropic Glutamate Receptor 5 Sales Market Share by Application (2021-2032) Figure 43. North America Metabotropic Glutamate Receptor 5 Revenue Share by Type (2021-2032) Figure 44. North America Metabotropic Glutamate Receptor 5 Sales Share by Type (2021-2032) Figure 45. North America Metabotropic Glutamate Receptor 5 Revenue Share by Application (2021-2032) Figure 46. North America Metabotropic Glutamate Receptor 5 Sales Share by Application (2021-2032) Figure 47. North America Metabotropic Glutamate Receptor 5 Revenue Share by Country (2021-2032) Figure 48. North America Metabotropic Glutamate Receptor 5 Sales Share by Country (2021-2032) Figure 49. Europe Metabotropic Glutamate Receptor 5 Revenue Share by Type (2021-2032) Figure 50. Europe Metabotropic Glutamate Receptor 5 Sales Share by Type (2021-2032) Figure 51. Europe Metabotropic Glutamate Receptor 5 Revenue Share by Application (2021-2032) Figure 52. Europe Metabotropic Glutamate Receptor 5 Sales Share by Application (2021-2032) Figure 53. Europe Metabotropic Glutamate Receptor 5 Revenue Share by Country (2021-2032) Figure 54. Europe Metabotropic Glutamate Receptor 5 Sales Share by Country (2021-2032) Figure 55. China Metabotropic Glutamate Receptor 5 Revenue Share by Type (2021-2032) Figure 56. China Metabotropic Glutamate Receptor 5 Sales Share by Type (2021-2032) Figure 57. China Metabotropic Glutamate Receptor 5 Revenue Share by Application (2021-2032) Figure 58. China Metabotropic Glutamate Receptor 5 Sales Share by Application (2021-2032) Figure 59. Asia Metabotropic Glutamate Receptor 5 Revenue Share by Type (2021-2032) Figure 60. Asia Metabotropic Glutamate Receptor 5 Sales Share by Type (2021-2032) Figure 61. Asia Metabotropic Glutamate Receptor 5 Revenue Share by Application (2021-2032) Figure 62. Asia Metabotropic Glutamate Receptor 5 Sales Share by Application (2021-2032) Figure 63. Asia Metabotropic Glutamate Receptor 5 Revenue Share by Country (2021-2032) Figure 64. Asia Metabotropic Glutamate Receptor 5 Sales Share by Country (2021-2032) Figure 65. SAMEA Metabotropic Glutamate Receptor 5 Revenue Share by Type (2021-2032) Figure 66. SAMEA Metabotropic Glutamate Receptor 5 Sales Share by Type (2021-2032) Figure 67. SAMEA Metabotropic Glutamate Receptor 5 Revenue Share by Application (2021-2032) Figure 68. SAMEA Metabotropic Glutamate Receptor 5 Sales Share by Application (2021-2032) Figure 69. SAMEA Metabotropic Glutamate Receptor 5 Revenue Share by Country (2021-2032) Figure 70. SAMEA Metabotropic Glutamate Receptor 5 Sales Share by Country (2021-2032) Figure 71. Metabotropic Glutamate Receptor 5 Value Chain Figure 72. Manufacturing Cost Structure Figure 73. Metabotropic Glutamate Receptor 5 Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Years Considered Figure 77. Research Process Figure 78. Key Executives Interviewed

Scope & coverage.

Types
  • Alloswitch-1
  • BMS-952048
  • BMS-955829
  • Dipraglurant ER
  • Others
Applications
  • Major Depressive Disorder
  • Alcohol Addiction
  • Alzheimer's Disease
  • Others
Companies covered
  • Addex Therapeutics Ltd
  • Aevi Genomic Medicine Inc
  • Bristol-Myers Squibb Company
  • Heptares Therapeutics Ltd
  • Merz Pharma GmbH & Co KgaA
  • Richter Gedeon Nyrt
  • Sumitomo Dainippon Pharma Co Ltd
  • Toray Industries Inc
  • Eli Lilly and Company
  • Novartis AG
  • Johnson & Johnson
  • Eisai Co Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Metabotropic Glutamate Receptor 5 Market by Type
  3. 1.2.1 Global Metabotropic Glutamate Receptor 5 Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Alloswitch-1
  5. 1.2.3 BMS-952048
  6. 1.2.4 BMS-955829
  7. 1.2.5 Dipraglurant ER
  8. 1.2.6 Others
  9. 1.3 Metabotropic Glutamate Receptor 5 Market by Application
  10. 1.3.1 Global Metabotropic Glutamate Receptor 5 Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Major Depressive Disorder
  12. 1.3.3 Alcohol Addiction
  13. 1.3.4 Alzheimer's Disease
  14. 1.3.5 Others
  15. 1.4 Assumptions and Limitations
  16. 1.5 Study Goals and Objectives
2 Metabotropic Glutamate Receptor 5 Market Dynamics
  1. 2.1 Metabotropic Glutamate Receptor 5 Industry Trends
  2. 2.2 Metabotropic Glutamate Receptor 5 Industry Drivers
  3. 2.3 Metabotropic Glutamate Receptor 5 Industry Opportunities and Challenges
  4. 2.4 Metabotropic Glutamate Receptor 5 Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Metabotropic Glutamate Receptor 5 Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Metabotropic Glutamate Receptor 5 Revenue by Region
  3. 3.2.1 Global Metabotropic Glutamate Receptor 5 Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Metabotropic Glutamate Receptor 5 Revenue by Region (2021-2026)
  5. 3.2.3 Global Metabotropic Glutamate Receptor 5 Revenue by Region (2027-2032)
  6. 3.2.4 Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Metabotropic Glutamate Receptor 5 Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Metabotropic Glutamate Receptor 5 Sales by Region
  9. 3.4.1 Global Metabotropic Glutamate Receptor 5 Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Metabotropic Glutamate Receptor 5 Sales by Region (2021-2026)
  11. 3.4.3 Global Metabotropic Glutamate Receptor 5 Sales by Region (2027-2032)
  12. 3.4.4 Global Metabotropic Glutamate Receptor 5 Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Metabotropic Glutamate Receptor 5 Revenue by Manufacturers
  2. 4.1.1 Global Metabotropic Glutamate Receptor 5 Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Metabotropic Glutamate Receptor 5 Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Metabotropic Glutamate Receptor 5 Sales by Manufacturers
  6. 4.2.1 Global Metabotropic Glutamate Receptor 5 Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Metabotropic Glutamate Receptor 5 Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Metabotropic Glutamate Receptor 5 Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Metabotropic Glutamate Receptor 5 Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Metabotropic Glutamate Receptor 5 Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Metabotropic Glutamate Receptor 5 Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Metabotropic Glutamate Receptor 5 Manufacturers, Product Type & Application
  13. 4.7 Global Metabotropic Glutamate Receptor 5 Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Metabotropic Glutamate Receptor 5 Market CR5 and HHI
  16. 4.8.2 2025 Metabotropic Glutamate Receptor 5 Tier 1, Tier 2, and Tier 3
5 Metabotropic Glutamate Receptor 5 Market by Type
  1. 5.1 Global Metabotropic Glutamate Receptor 5 Revenue by Type
  2. 5.1.1 Global Metabotropic Glutamate Receptor 5 Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Metabotropic Glutamate Receptor 5 Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Metabotropic Glutamate Receptor 5 Sales by Type
  6. 5.2.1 Global Metabotropic Glutamate Receptor 5 Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Metabotropic Glutamate Receptor 5 Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Metabotropic Glutamate Receptor 5 Sales Market Share by Type (2021-2032)
  9. 5.3 Global Metabotropic Glutamate Receptor 5 Price by Type
6 Metabotropic Glutamate Receptor 5 Market by Application
  1. 6.1 Global Metabotropic Glutamate Receptor 5 Revenue by Application
  2. 6.1.1 Global Metabotropic Glutamate Receptor 5 Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Metabotropic Glutamate Receptor 5 Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Metabotropic Glutamate Receptor 5 Sales by Application
  6. 6.2.1 Global Metabotropic Glutamate Receptor 5 Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Metabotropic Glutamate Receptor 5 Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Metabotropic Glutamate Receptor 5 Sales Market Share by Application (2021-2032)
  9. 6.3 Global Metabotropic Glutamate Receptor 5 Price by Application
7 Company Profiles
  1. 7.1 Addex Therapeutics Ltd
  2. 7.1.1 Addex Therapeutics Ltd Company Information
  3. 7.1.2 Addex Therapeutics Ltd Business Overview
  4. 7.1.3 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 5 Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 5 Product Portfolio
  6. 7.1.5 Addex Therapeutics Ltd Recent Developments
  7. 7.2 Aevi Genomic Medicine Inc
  8. 7.2.1 Aevi Genomic Medicine Inc Company Information
  9. 7.2.2 Aevi Genomic Medicine Inc Business Overview
  10. 7.2.3 Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 5 Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 5 Product Portfolio
  12. 7.2.5 Aevi Genomic Medicine Inc Recent Developments
  13. 7.3 Bristol-Myers Squibb Company
  14. 7.3.1 Bristol-Myers Squibb Company Company Information
  15. 7.3.2 Bristol-Myers Squibb Company Business Overview
  16. 7.3.3 Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 5 Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 5 Product Portfolio
  18. 7.3.5 Bristol-Myers Squibb Company Recent Developments
  19. 7.4 Heptares Therapeutics Ltd
  20. 7.4.1 Heptares Therapeutics Ltd Company Information
  21. 7.4.2 Heptares Therapeutics Ltd Business Overview
  22. 7.4.3 Heptares Therapeutics Ltd Metabotropic Glutamate Receptor 5 Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Heptares Therapeutics Ltd Metabotropic Glutamate Receptor 5 Product Portfolio
  24. 7.4.5 Heptares Therapeutics Ltd Recent Developments
  25. 7.5 Merz Pharma GmbH & Co KgaA
  26. 7.5.1 Merz Pharma GmbH & Co KgaA Company Information
  27. 7.5.2 Merz Pharma GmbH & Co KgaA Business Overview
  28. 7.5.3 Merz Pharma GmbH & Co KgaA Metabotropic Glutamate Receptor 5 Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Merz Pharma GmbH & Co KgaA Metabotropic Glutamate Receptor 5 Product Portfolio
  30. 7.5.5 Merz Pharma GmbH & Co KgaA Recent Developments
  31. 7.6 Richter Gedeon Nyrt
  32. 7.6.1 Richter Gedeon Nyrt Company Information
  33. 7.6.2 Richter Gedeon Nyrt Business Overview
  34. 7.6.3 Richter Gedeon Nyrt Metabotropic Glutamate Receptor 5 Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Richter Gedeon Nyrt Metabotropic Glutamate Receptor 5 Product Portfolio
  36. 7.6.5 Richter Gedeon Nyrt Recent Developments
  37. 7.7 Sumitomo Dainippon Pharma Co Ltd
  38. 7.7.1 Sumitomo Dainippon Pharma Co Ltd Company Information
  39. 7.7.2 Sumitomo Dainippon Pharma Co Ltd Business Overview
  40. 7.7.3 Sumitomo Dainippon Pharma Co Ltd Metabotropic Glutamate Receptor 5 Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Sumitomo Dainippon Pharma Co Ltd Metabotropic Glutamate Receptor 5 Product Portfolio
  42. 7.7.5 Sumitomo Dainippon Pharma Co Ltd Recent Developments
  43. 7.8 Toray Industries Inc
  44. 7.8.1 Toray Industries Inc Company Information
  45. 7.8.2 Toray Industries Inc Business Overview
  46. 7.8.3 Toray Industries Inc Metabotropic Glutamate Receptor 5 Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Toray Industries Inc Metabotropic Glutamate Receptor 5 Product Portfolio
  48. 7.8.5 Toray Industries Inc Recent Developments
  49. 7.9 Eli Lilly and Company
  50. 7.9.1 Eli Lilly and Company Company Information
  51. 7.9.2 Eli Lilly and Company Business Overview
  52. 7.9.3 Eli Lilly and Company Metabotropic Glutamate Receptor 5 Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Eli Lilly and Company Metabotropic Glutamate Receptor 5 Product Portfolio
  54. 7.9.5 Eli Lilly and Company Recent Developments
  55. 7.10 Novartis AG
  56. 7.10.1 Novartis AG Company Information
  57. 7.10.2 Novartis AG Business Overview
  58. 7.10.3 Novartis AG Metabotropic Glutamate Receptor 5 Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Novartis AG Metabotropic Glutamate Receptor 5 Product Portfolio
  60. 7.10.5 Novartis AG Recent Developments
  61. 7.11 Johnson & Johnson
  62. 7.11.1 Johnson & Johnson Company Information
  63. 7.11.2 Johnson & Johnson Business Overview
  64. 7.11.3 Johnson & Johnson Metabotropic Glutamate Receptor 5 Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Johnson & Johnson Metabotropic Glutamate Receptor 5 Product Portfolio
  66. 7.11.5 Johnson & Johnson Recent Developments
  67. 7.12 Eisai Co Ltd
  68. 7.12.1 Eisai Co Ltd Company Information
  69. 7.12.2 Eisai Co Ltd Business Overview
  70. 7.12.3 Eisai Co Ltd Metabotropic Glutamate Receptor 5 Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Eisai Co Ltd Metabotropic Glutamate Receptor 5 Product Portfolio
  72. 7.12.5 Eisai Co Ltd Recent Developments
8 North America
  1. 8.1 North America Metabotropic Glutamate Receptor 5 Market Size by Type
  2. 8.1.1 North America Metabotropic Glutamate Receptor 5 Revenue by Type (2021-2032)
  3. 8.1.2 North America Metabotropic Glutamate Receptor 5 Sales by Type (2021-2032)
  4. 8.1.3 North America Metabotropic Glutamate Receptor 5 Price by Type (2021-2032)
  5. 8.2 North America Metabotropic Glutamate Receptor 5 Market Size by Application
  6. 8.2.1 North America Metabotropic Glutamate Receptor 5 Revenue by Application (2021-2032)
  7. 8.2.2 North America Metabotropic Glutamate Receptor 5 Sales by Application (2021-2032)
  8. 8.2.3 North America Metabotropic Glutamate Receptor 5 Price by Application (2021-2032)
  9. 8.3 North America Metabotropic Glutamate Receptor 5 Market Size by Country
  10. 8.3.1 North America Metabotropic Glutamate Receptor 5 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Metabotropic Glutamate Receptor 5 Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Metabotropic Glutamate Receptor 5 Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Metabotropic Glutamate Receptor 5 Market Size by Type
  2. 9.1.1 Europe Metabotropic Glutamate Receptor 5 Revenue by Type (2021-2032)
  3. 9.1.2 Europe Metabotropic Glutamate Receptor 5 Sales by Type (2021-2032)
  4. 9.1.3 Europe Metabotropic Glutamate Receptor 5 Price by Type (2021-2032)
  5. 9.2 Europe Metabotropic Glutamate Receptor 5 Market Size by Application
  6. 9.2.1 Europe Metabotropic Glutamate Receptor 5 Revenue by Application (2021-2032)
  7. 9.2.2 Europe Metabotropic Glutamate Receptor 5 Sales by Application (2021-2032)
  8. 9.2.3 Europe Metabotropic Glutamate Receptor 5 Price by Application (2021-2032)
  9. 9.3 Europe Metabotropic Glutamate Receptor 5 Market Size by Country
  10. 9.3.1 Europe Metabotropic Glutamate Receptor 5 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Metabotropic Glutamate Receptor 5 Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Metabotropic Glutamate Receptor 5 Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Metabotropic Glutamate Receptor 5 Market Size by Type
  2. 10.1.1 China Metabotropic Glutamate Receptor 5 Revenue by Type (2021-2032)
  3. 10.1.2 China Metabotropic Glutamate Receptor 5 Sales by Type (2021-2032)
  4. 10.1.3 China Metabotropic Glutamate Receptor 5 Price by Type (2021-2032)
  5. 10.2 China Metabotropic Glutamate Receptor 5 Market Size by Application
  6. 10.2.1 China Metabotropic Glutamate Receptor 5 Revenue by Application (2021-2032)
  7. 10.2.2 China Metabotropic Glutamate Receptor 5 Sales by Application (2021-2032)
  8. 10.2.3 China Metabotropic Glutamate Receptor 5 Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Metabotropic Glutamate Receptor 5 Market Size by Type
  2. 11.1.1 Asia Metabotropic Glutamate Receptor 5 Revenue by Type (2021-2032)
  3. 11.1.2 Asia Metabotropic Glutamate Receptor 5 Sales by Type (2021-2032)
  4. 11.1.3 Asia Metabotropic Glutamate Receptor 5 Price by Type (2021-2032)
  5. 11.2 Asia Metabotropic Glutamate Receptor 5 Market Size by Application
  6. 11.2.1 Asia Metabotropic Glutamate Receptor 5 Revenue by Application (2021-2032)
  7. 11.2.2 Asia Metabotropic Glutamate Receptor 5 Sales by Application (2021-2032)
  8. 11.2.3 Asia Metabotropic Glutamate Receptor 5 Price by Application (2021-2032)
  9. 11.3 Asia Metabotropic Glutamate Receptor 5 Market Size by Country
  10. 11.3.1 Asia Metabotropic Glutamate Receptor 5 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Metabotropic Glutamate Receptor 5 Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Metabotropic Glutamate Receptor 5 Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Metabotropic Glutamate Receptor 5 Market Size by Type
  2. 12.1.1 SAMEA Metabotropic Glutamate Receptor 5 Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Metabotropic Glutamate Receptor 5 Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Metabotropic Glutamate Receptor 5 Price by Type (2021-2032)
  5. 12.2 SAMEA Metabotropic Glutamate Receptor 5 Market Size by Application
  6. 12.2.1 SAMEA Metabotropic Glutamate Receptor 5 Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Metabotropic Glutamate Receptor 5 Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Metabotropic Glutamate Receptor 5 Price by Application (2021-2032)
  9. 12.3 SAMEA Metabotropic Glutamate Receptor 5 Market Size by Country
  10. 12.3.1 SAMEA Metabotropic Glutamate Receptor 5 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Metabotropic Glutamate Receptor 5 Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Metabotropic Glutamate Receptor 5 Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Metabotropic Glutamate Receptor 5 Value Chain Analysis
  2. 13.1.1 Metabotropic Glutamate Receptor 5 Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Metabotropic Glutamate Receptor 5 Production Mode & Process
  6. 13.2 Metabotropic Glutamate Receptor 5 Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Metabotropic Glutamate Receptor 5 Distributors
  9. 13.2.3 Metabotropic Glutamate Receptor 5 Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst